Global Intravenous Iron Drug Market Size, Competitive Analysis, Share, Forecast- 2020-2026


Posted October 7, 2020 by preeti18

The global intravenous iron drug market is projected to grow at a CAGR of around 7% during the forecast period.

 
The global intravenous iron drug market is projected to grow at a CAGR of around 7% during the forecast period. Iron plays a vital role in the human body; it transfers oxygen via blood throughout the body. The deficit of iron is one of the foremost causes of iron deficiency anemia (IDA) allied with more diseases and even mortality. The primary factors driving the growth of the market include iron deficiency cases across the globe. An increasing number of disorders including oncology, chronic heart failures, nephrology, gynecology, gastroenterology, and others also creates a scope for market growth.
Get Free Sample Copy @ https://www.omrglobal.com/request-sample/intravenous-iron-drug-market
Moreover, a growing number of diabetic patients across the globe, an increase in the number of dialysis patients, along with the increasing aging population are some other factors that support the growth of the market. However, some of the side effects associated with the drugs including nausea, headache, back pain, muscle cramps, joint pain, which are likely to hinder the growth of the market. Stringent government regulations imposed on the endorsement and usage of these drugs is also hampering the growth of the market during the forecast period.
Browse for Full Report [email protected] https://www.omrglobal.com/industry-reports/intravenous-iron-drug-market
Market Segmentation
Global Intravenous Iron Drug Market by Product
• Ferric Carboxymaltose
• Iron Sucrose
• Iron Dextran
• Others (Ferric Gluconate)
Global Intravenous Iron Drug Market by Application
• Oncology
• Chronic Kidney Diseases
• Inflammatory Bowel Diseases
• Others
Regional Analysis
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• Rest of Asia-Pacific
Rest of the World
Company Profiles
• Akebia Therapeutics, Inc.
• Allergan PLC
• AMAG Pharmaceuticals, Inc.
• American Regent, Inc.
• AstraZeneca PLC
• Bristol-Myers Squibb Co.
• Daiichi Sankyo Co., Ltd.
• FibroGen
• Pieris Pharmaceuticals Inc.
• Pharmacosmos Group
• Rockwell Medical, Inc.
• Sanofi SA
• Shield Therapeutics Plc
• Vifor Pharma Management Ltd.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/intravenous-iron-drug-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 780-304-0404
-- END ---
Contact Email [email protected]
Issued By Preeti
Country India
Categories Business
Tags Global Intravenous Iron Drug Market
Last Updated October 7, 2020